These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27796157)

  • 1. Management of elderly and unfit patients with chronic lymphocytic leukemia.
    Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
    Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
    Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
    Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia - are we ready for chemo-free immunotherapy approach?
    Milunović V; Mišura Jakobac K; Mandac Rogulj I; Martinović M; Radić-Krišto D; Ostojić Kolonić S
    Expert Rev Hematol; 2020 Jul; 13(7):771-779. PubMed ID: 32579408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies BN; Stephens DM
    Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial therapy of chronic lymphocytic leukemia.
    Eichhorst B; Cramer P; Hallek M
    Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia.
    Rai KR
    J Hematol Oncol; 2015 Jul; 8():85. PubMed ID: 26170206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of unfit elderly patients with chronic lymphocytic leukemia.
    Eichhorst B; Hallek M; Goede V
    Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia.
    Mauro FR; Caputo MD; Rosati S; Pepe S; De Benedittis D; De Luca ML; Foà R
    Expert Rev Hematol; 2018 Aug; 11(8):601-611. PubMed ID: 29969322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
    Iovino L; Shadman M
    Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic markers and standard management of chronic lymphocytic leukemia.
    Stilgenbauer S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
    Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Byrd JC; Czuczman MS; Fayad LE; Fisher RI; Glenn MJ; Habermann TM; Harris NL; Hoppe RT; Horwitz SM; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Saad AA; Sokol L; Swinnen LJ; Tsien C; Vose JM; Wilson L; Yahalom J; Zafar N; Dwyer M; Sundar H;
    J Natl Compr Canc Netw; 2015 Mar; 13(3):326-62. PubMed ID: 25736010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options.
    Sharma S; Rai KR
    Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial.
    Molica S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):9-15. PubMed ID: 25479582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
    Takizawa J
    Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.
    Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V
    Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
    Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored Treatment Strategies for Chronic Lymphocytic Leukemia in a Rapidly Changing Era.
    Brander D; Islam P; Barrientos JC
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():487-498. PubMed ID: 31099686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
    Cramer P; Hallek M; Eichhorst B
    Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia.
    Seiter K; Mamorska-Dyga A
    Clin Interv Aging; 2015; 10():951-61. PubMed ID: 26109852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.